FRMD6 and metastatic neoplasm: The results of transwell assays also demonstrated that the forced expression of FRMD6 clearly impaired the mobility of PCa cells (Figure 7F), which was consistent with lower levels of FRMD6 in metastatic tumors (Figure 7B).